HOME
Universe A-Z
PSYCH STOCK NEWS
PSYCH NEWS
RESEARCH
TESTIMONIALS
CLINICAL TRIALS
CONFERENCES
2023 PSYCHEDELIC INVESTOR CONFERENCE
Search
LARGE CAP PSYCH
2023 Watch List
CLIENT
CLINICAL TRIALS
CLINICS
CONFERENCES
DECK
INTERVIEW
INVESTORS
IPO
LARGE CAP PSYCH
NEO
PSYCH FUND | ETF
PSYCH NEWS
PSYCH STOCK NEWS
Psychedelic Investor Guide
Psychedelic Investor TV
RESEARCH
SIDE STORIES
STUFF
SUBSCRIBE
TESTIMONIALS
UNIVERSE
VIDEOS
Is ATAI Live Sciences (ATAI) $2.00, Finally Turning?
Editor | Curator
-
April 24, 2023
Australian Icannex (IHL:ASX) Headed to NASDAQ?
Editor | Curator
-
February 10, 2022
Small Pharma (DMT, DMTTF) $0.46 a Small and Extremely Interesting Psychedelic...
Editor | Curator
-
November 4, 2021
Interview: Great Interview With Cybin (CYBN) CEO Doug Drysdale.
September 29, 2021
MindMed (MNMD) and Liechti Lab Provide Results from their Psilocybin R&D...
September 23, 2021
Huge News on Opioid Addiction From atai (ATAI).
September 21, 2021
Compass Pathways (CMPS) Reports 2Q and Business Highlights.
August 12, 2021
Atai Life Sciences (ATAI) Presentation Deck.
August 8, 2021
Atai Life Sciences (ATAI)
August 4, 2021
Compass Pathways (CMPS)
August 3, 2021
MindMed (MNMD)
August 1, 2021
Cybin (CYBN) Enters into Collaboration Agreement with Greenbrook TMS (GBNH) to...
June 17, 2021
